{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:31:23Z","timestamp":1784694683312,"version":"3.55.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00467-025-06882-3","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T03:59:50Z","timestamp":1751947190000},"page":"649-662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Technicalities, current evidence, and clinical indications of hemoadsorption in critically ill children"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1881-9989","authenticated-orcid":false,"given":"Giovanni","family":"Ceschia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germana","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e8","family":"Igeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"6882_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000533468","volume":"53","author":"M Ostermann","year":"2024","unstructured":"Ostermann M, Ankawi G, Cantaluppi V, Madarasu R, Dolan K, Husain-Syed F, Kashani K, Mehta R, Prowle J, Reis T, Rimmel\u00e9 T, Zarbock A, Kellum JA, Ronco C; Nomenclature Standardization Faculty (2024) Nomenclature of extracorporeal blood purification therapies for acute indications: the nomenclature standardization conference. Blood Purif 53:358\u2013372. https:\/\/doi.org\/10.1159\/000533468","journal-title":"Blood Purif"},{"key":"6882_CR2","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00134-022-06810-1","volume":"48","author":"Z Ricci","year":"2022","unstructured":"Ricci Z, Romagnoli S, Reis T, Bellomo R, Ronco C (2022) Hemoperfusion in the intensive care unit. Intensive Care Med 48:1397\u20131408. https:\/\/doi.org\/10.1007\/s00134-022-06810-1","journal-title":"Intensive Care Med"},{"key":"6882_CR3","doi-asserted-by":"publisher","unstructured":"Bellomo R, Ankawi G, Bagshaw SM, Baldwin I, Basu R, Bottari G, Cantaluppi V, Clark W, De Rosa S, Forni LG, Fuhrman D, Goldstein S, Gomez H, Husain-Syed F, Joannidis M, Kashani K, Lorenzin A, Mehta R, Murray PT, Murugan R \u2026 Zarbock A (2024) Hemoadsorption: consensus report of the 30th Acute Disease Quality Initiative workgroup. Nephrol Dial Transplant 39:1945\u20131964. https:\/\/doi.org\/10.1093\/ndt\/gfae089","DOI":"10.1093\/ndt\/gfae089"},{"key":"6882_CR4","doi-asserted-by":"publisher","unstructured":"Bellomo R, Mehta RL, Forni LG, Zarbock A, Ostermann M, Ronco C; Acute disease quality initiative hemoadsorption working group (2024) hemoadsorption. Clin J Am Soc Nephrol 19:803\u2013806. https:\/\/doi.org\/10.2215\/CJN.0000000000000433","DOI":"10.2215\/CJN.0000000000000433"},{"key":"6882_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000529904","volume":"200","author":"PP Duchini","year":"2023","unstructured":"Duchini PP, Bottari G, Deep A, Ricci Z (2023) Hemadsorption in critically ill children. Contrib Nephrol 200:242\u2013251. https:\/\/doi.org\/10.1159\/000529904","journal-title":"Contrib Nephrol"},{"key":"6882_CR6","doi-asserted-by":"publisher","first-page":"R93","DOI":"10.1186\/cc6965","volume":"12","author":"J del Castillo","year":"2008","unstructured":"del Castillo J, L\u00f3pez-Herce J, Cidoncha E, Urbano J, Menc\u00eda S, Santiago MJ, Bell\u00f3n JM (2008) Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study. Crit Care 12:R93. https:\/\/doi.org\/10.1186\/cc6965","journal-title":"Crit Care"},{"key":"6882_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/MAT.0b013e3182816a75","volume":"59","author":"PM Honore","year":"2013","unstructured":"Honore PM, Jacobs R, Joannes-Boyau O, De Regt J, De Waele E, van Gorp V, Boer W, Verfaillie L, Spapen HD (2013) Newly designed CRRT membranes for sepsis and SIRS\u2013a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review. ASAIO J 59:99\u2013106. https:\/\/doi.org\/10.1097\/MAT.0b013e3182816a75","journal-title":"ASAIO J"},{"key":"6882_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000074937","volume":"22","author":"C Ronco","year":"2004","unstructured":"Ronco C, Bonello M, Bordoni V, Ricci Z, D\u2019Intini V, Bellomo R, Levin NW (2004) Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif 22:164\u2013174. https:\/\/doi.org\/10.1159\/000074937","journal-title":"Blood Purif"},{"key":"6882_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcrc.2018.11.003","volume":"49","author":"F Hawchar","year":"2019","unstructured":"Hawchar F, L\u00e1szl\u00f3 I, \u00d6veges N, Tr\u00e1sy D, Ondrik Z, Molnar Z (2019) Extracorporeal cytokine adsorption in septic shock: a proof of concept randomized, controlled pilot study. J Crit Care 49:172\u2013178. https:\/\/doi.org\/10.1016\/j.jcrc.2018.11.003","journal-title":"J Crit Care"},{"key":"6882_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1159\/000530446","volume":"52","author":"T Siripanadorn","year":"2023","unstructured":"Siripanadorn T, Samransamruajkit R (2023) The role of blood purification by HA330 as adjunctive treatment in children with septic shock. Blood Purif 52:549\u2013555. https:\/\/doi.org\/10.1159\/000530446","journal-title":"Blood Purif"},{"key":"6882_CR11","doi-asserted-by":"publisher","first-page":"1259384","DOI":"10.3389\/fped.2023.1259384","volume":"11","author":"G Bottari","year":"2023","unstructured":"Bottari G, Guzzo I, Cappoli A, Labbadia R, Perdichizzi S, Serpe C, Creteur J, Cecchetti C, Taccone FS (2023) Impact of CytoSorb and CKRT on hemodynamics in pediatric patients with septic shock: the PedCyto study. Front Pediatr 11:1259384. https:\/\/doi.org\/10.3389\/fped.2023.1259384","journal-title":"Front Pediatr"},{"key":"6882_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1159\/000530147","volume":"52","author":"L Morin","year":"2023","unstructured":"Morin L, Charbel R, Cousin VL, Marais C, Claude C, Barreault S, Durand P, Miatello J, Tissi\u00e8res P (2023) Blood purification with oXiris\u00a9 in critically ill children with vasoplegic shock. Blood Purif 52:541\u2013548. https:\/\/doi.org\/10.1159\/000530147","journal-title":"Blood Purif"},{"key":"6882_CR13","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s00134-018-5463-7","volume":"44","author":"DJ Klein","year":"2018","unstructured":"Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H, Antonelli M (2018) Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive care Med 44:2205\u20132212. https:\/\/doi.org\/10.1007\/s00134-018-5463-7","journal-title":"Intensive care Med"},{"key":"6882_CR14","doi-asserted-by":"publisher","unstructured":"Bottari G, Di Nardo M, Gleeson J, Minoia F, Moscatelli A, Cecchetti C, Verrina EE (2019) Extracorporeal blood purification techniques in children with hyper-inflammatory syndromes: a clinical overview. Minerva Anestesiol\u00a085:531\u2013542. https:\/\/doi.org\/10.23736\/S0375-9393.19.13189-6","DOI":"10.23736\/S0375-9393.19.13189-6"},{"key":"6882_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13054-023-04391-z","volume":"27","author":"A Jansen","year":"2023","unstructured":"Jansen A, Waalders NJB, van Lier DPT, Kox M, Pickkers P (2023) CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo. Crit Care 27:117. https:\/\/doi.org\/10.1186\/s13054-023-04391-z","journal-title":"Crit Care"},{"key":"6882_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/biomedicines12010067","volume":"12","author":"C Turan","year":"2023","unstructured":"Turan C, Szigetv\u00e1ry CE, K\u00f3i T, Engh MA, Atakan I, Zubek L, Terebessy T, Hegyi P, Moln\u00e1r Z (2023) Hemoadsorption therapy for critically ill patients with acute liver dysfunction: a meta-analysis and systematic review. Biomedicines 12:67. https:\/\/doi.org\/10.3390\/biomedicines12010067","journal-title":"Biomedicines"},{"key":"6882_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12882-024-03679-8","volume":"25","author":"L Forni","year":"2024","unstructured":"Forni L, Aucella F, Bottari G, B\u00fcttner S, Cantaluppi V, Fries D, Kielstein J, Kindgen-Milles D, Krenn C, Kribben A, Meiser A, Mitzner S, Ostermann M, Premuzic V, Rolfes C, Scharf C, Schunk S, Molnar Z, Zarbock A (2024) Hemoadsorption therapy for myoglobin removal in rhabdomyolysis: consensus of the hemoadsorption in rhabdomyolysis task force. BMC Nephrol 25:247. https:\/\/doi.org\/10.1186\/s12882-024-03679-8","journal-title":"BMC Nephrol"},{"key":"6882_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13054-021-03468-x","volume":"25","author":"C Scharf","year":"2021","unstructured":"Scharf C, Liebchen U, Paal M, Irlbeck M, Zoller M, Schroeder I (2021) Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis. Crit Care 25:41. https:\/\/doi.org\/10.1186\/s13054-021-03468-x","journal-title":"Crit Care"},{"key":"6882_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12882-025-03945-3","volume":"26","author":"L Weidhase","year":"2025","unstructured":"Weidhase L, Borrmann A, Willenberg A, Mende M, Scharf-Jan\u00dfen C, Petros S, de Fallois J (2025) Kidney REPLACEment therapies in patients with acute kidney injury and RHABDOmyolysis (ReplaceRhabdo): a pilot trial. BMC Nephrol 26:23. https:\/\/doi.org\/10.1186\/s12882-025-03945-3","journal-title":"BMC Nephrol"},{"key":"6882_CR20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1053\/j.semtcvs.2019.05.006","volume":"31","author":"TG Gleason","year":"2019","unstructured":"Gleason TG, Argenziano M, Bavaria JE, Kane LC, Coselli JS, Engelman RM, Tanaka KA, Awad A, Sekela ME, Zwischenberger JB (2019) Hemoadsorption to reduce plasma-free hemoglobin during cardiac surgery: results of REFRESH I pilot study. Semin Thorac Cardiovasc Surg 31:783\u2013793. https:\/\/doi.org\/10.1053\/j.semtcvs.2019.05.006","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"6882_CR21","doi-asserted-by":"publisher","unstructured":"Bao Y, Wang X, Zi Y, Qian X, Li Y, Li S, Wang Z (2024) Hemoadsorption during cardiopulmonary bypass to absorb plasma-free hemoglobin in patients with acute type a aortic dissection: a randomized controlled trial.\u00a0Perfusion 2676591241305276. https:\/\/doi.org\/10.1177\/02676591241305276","DOI":"10.1177\/02676591241305276"},{"key":"6882_CR22","doi-asserted-by":"publisher","unstructured":"Diab M, Lehmann T, Bothe W, Akhyari P, Platzer S, Wendt D, Deppe AC, Strauch J, Hagel S, G\u00fcnther A, Faerber G, Sponholz C, Franz M, Scherag A, Velichkov I, Silaschi M, Fassl J, Hofmann B, Lehmann S, Schramm R \u2026 REMOVE Trial Investigators* (2022) Cytokine hemoadsorption during cardiac surgery versus standard surgical care for infective endocarditis (REMOVE): results from a multicenter randomized controlled trial. Circulation\u00a0145:959\u2013968. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.056940","DOI":"10.1161\/CIRCULATIONAHA.121.056940"},{"key":"6882_CR23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s13054-024-05175-9","volume":"28","author":"A Hohn","year":"2024","unstructured":"Hohn A, Malewicz-Oeck NM, Buchwald D, Annecke T, Zahn PK, Baumann A (2024) REmoval of cytokines during CArdiac surgery (RECCAS): a randomised controlled trial. Crit Care 28:406. https:\/\/doi.org\/10.1186\/s13054-024-05175-9","journal-title":"Crit Care"},{"key":"6882_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13054-023-04323-x","volume":"27","author":"C Monard","year":"2023","unstructured":"Monard C, Bianchi N, Poli E, Altarelli M, Debonneville A, Oddo M, Liaudet L, Schneider A (2023) Cytokine hemoadsorption with CytoSorb\u00ae in post-cardiac arrest syndrome, a pilot randomized controlled trial. Crit Care 27:36. https:\/\/doi.org\/10.1186\/s13054-023-04323-x","journal-title":"Crit Care"},{"key":"6882_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S2213-2600(21)00177-6","volume":"9","author":"A Supady","year":"2021","unstructured":"Supady A, Weber E, Rieder M, Lother A, Niklaus T, Zahn T, Frech F, M\u00fcller S, Kuhl M, Benk C, Maier S, Trummer G, Fl\u00fcgler A, Kr\u00fcger K, Sekandarzad A, Stachon P, Zotzmann V, Bode C, Biever PM, Staudacher D, Wengenmayer T, Graf E, Duerschmied D (2021) Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial. Lancet Respir Med 9:755\u2013762. https:\/\/doi.org\/10.1016\/S2213-2600(21)00177-6","journal-title":"Lancet Respir Med"},{"key":"6882_CR26","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/aor.14774","volume":"48","author":"A Sekandarzad","year":"2024","unstructured":"Sekandarzad A, Graf E, Prager EP, Luxenburger H, Staudacher DL, Wengenmayer T, Bettinger D, Supady A (2024) Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP): a single center, open-label, three-arm, randomized, controlled intervention pilot trial. Artif Organs 48:1150\u20131161. https:\/\/doi.org\/10.1111\/aor.14774","journal-title":"Artif Organs"},{"key":"6882_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13054-023-04492-9","volume":"27","author":"S Becker","year":"2023","unstructured":"Becker S, Lang H, Vollmer Barbosa C, Tian Z, Melk A, Schmidt BMW (2023) Efficacy of CytoSorb\u00ae: a systematic review and meta-analysis. Crit Care 27:215. https:\/\/doi.org\/10.1186\/s13054-023-04492-9","journal-title":"Crit Care"},{"key":"6882_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13054-016-1270-0","volume":"20","author":"MH Bernardi","year":"2016","unstructured":"Bernardi MH, Rinoesl H, Dragosits K, Ristl R, Hoffelner F, Opfermann P, Lamm C, Prei\u00dfing F, Wiedemann D, Hiesmayr MJ, Spittler A (2016) Effect of hemoadsorption during cardiopulmonary bypass surgery - a blinded, randomized, controlled pilot study using a novel adsorbent. Crit Care 20:96. https:\/\/doi.org\/10.1186\/s13054-016-1270-0","journal-title":"Crit Care"},{"key":"6882_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000517471","volume":"51","author":"G Bottari","year":"2022","unstructured":"Bottari G, Murciano M, Merli P, Bracaglia C, Guzzo I, Stoppa F, Pardeo M, Nunziata J, Del Bufalo F, Genuini L, De Benedetti F, Locatelli F, Cecchetti C (2022) Hemoperfusion with CytoSorb to manage multiorgan dysfunction in the spectrum of hemophagocytic lymphohistiocytosis syndrome in critically ill children. Blood Purif 51:417\u2013424. https:\/\/doi.org\/10.1159\/000517471","journal-title":"Blood Purif"},{"key":"6882_CR30","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.3390\/jcm13216587","volume":"13","author":"E Rihar","year":"2024","unstructured":"Rihar E, Per\u0161i\u010d V, Jerman A, Plankar Srovin T, Mlakar G, Bezeljak N, Pokorn M, Fister P (2024) Hemoperfusion with CytoSorb\u00ae in pediatric patients: a monocentric case series. J Clin Med 13:6587. https:\/\/doi.org\/10.3390\/jcm13216587","journal-title":"J Clin Med"},{"key":"6882_CR31","doi-asserted-by":"publisher","first-page":"6987167","DOI":"10.1155\/2017\/6987167","volume":"2017","author":"CG Cirstoveanu","year":"2017","unstructured":"Cirstoveanu CG, Barascu I, Mc Kenzie Stancu S (2017) Hemadsorption with adult CytoSorb\u00ae in a low weight pediatric case. Case Rep Crit Care 2017:6987167. https:\/\/doi.org\/10.1155\/2017\/6987167","journal-title":"Case Rep Crit Care"},{"key":"6882_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.718049","volume":"9","author":"G Bottari","year":"2021","unstructured":"Bottari G, Lorenzetti G, Severini F, Cappoli A, Cecchetti C, Guzzo I (2021) Role of hemoperfusion with CytoSorb associated with continuous kidney replacement therapy on renal outcome in critically ill children with septic shock. Front Pediatr 9:718049. https:\/\/doi.org\/10.3389\/fped.2021.718049","journal-title":"Front Pediatr"},{"key":"6882_CR33","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1177\/0391398820902469","volume":"43","author":"G Bottari","year":"2020","unstructured":"Bottari G, Guzzo I, Marano M, Stoppa F, Rav\u00e0 L, Di Nardo M, Cecchetti C (2020) Hemoperfusion with Cytosorb in pediatric patients with septic shock: a retrospective observational study. Int J Artif Organs 43:587\u2013593. https:\/\/doi.org\/10.1177\/0391398820902469","journal-title":"Int J Artif Organs"},{"key":"6882_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13054-024-04802-9","volume":"28","author":"G Bottari","year":"2024","unstructured":"Bottari G, Cecchetti C, Serpe C, Grimaldi D, Taccone FS (2024) Potential correlation between hemodynamic improvement and an immune-modulation effect in pediatric patients with septic shock treated with renal replacement therapy and CytoSorb\u00ae: an insight from the PedCyto study. Crit Care 28:25. https:\/\/doi.org\/10.1186\/s13054-024-04802-9","journal-title":"Crit Care"},{"key":"6882_CR35","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/biomedicines12071435","volume":"12","author":"G Bottari","year":"2024","unstructured":"Bottari G, Confalone V, Creteur J, Cecchetti C, Taccone FS (2024) The sublingual microcirculation in critically ill children with septic shock undergoing hemoadsorption: a pilot study. Biomedicines 12:1435. https:\/\/doi.org\/10.3390\/biomedicines12071435","journal-title":"Biomedicines"},{"key":"6882_CR36","doi-asserted-by":"publisher","DOI":"10.2196\/55880","volume":"13","author":"FS Taccone","year":"2024","unstructured":"Taccone FS, Brunkhorst FM, Bottari G, Hidalgo J, Kribben A, Teboul JL, Tomescu D, Klaus T, Scheier J, Deliargyris E, Ferrer R (2024) The COSMOS Registry of CytoSorb hemoadsorption therapy in critically ill patients: protocol for an international, prospective registry. JMIR Res Protoc 13:e55880. https:\/\/doi.org\/10.2196\/55880","journal-title":"JMIR Res Protoc"},{"key":"6882_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000514149","volume":"51","author":"Z He","year":"2022","unstructured":"He Z, Lu H, Jian X, Li G, Xiao D, Meng Q, Chen J, Zhou C (2022) The efficacy of resin hemoperfusion cartridge on inflammatory responses during adult cardiopulmonary bypass. Blood Purif 51:31\u201337. https:\/\/doi.org\/10.1159\/000514149","journal-title":"Blood Purif"},{"key":"6882_CR38","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1159\/000540584","volume":"53","author":"K Surasit","year":"2024","unstructured":"Surasit K, Srisawat N (2024) The role of early hemoadsorption in severe COVID-19 treatment: a pilot randomized controlled trial. Blood Purif 53:793\u2013803. https:\/\/doi.org\/10.1159\/000540584","journal-title":"Blood Purif"},{"key":"6882_CR39","doi-asserted-by":"publisher","unstructured":"Condello I, Morvillo JB, Fiore F, Teora V, Nasso G, Speziale G (2024) Hemadsorption to contain postoperative cell-free hemoglobin and haptoglobin preservation for extended cardiopulmonary bypass time in cardiac surgery for acute kidney injuries prevention. Braz J Cardiovasc Surg 39:e20230272. https:\/\/doi.org\/10.21470\/1678-9741-2023-0272","DOI":"10.21470\/1678-9741-2023-0272"},{"key":"6882_CR40","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/1744-9987.14108","volume":"28","author":"J Zhou","year":"2024","unstructured":"Zhou J, Li H, Zhang L, Chen G, Wang G, Zhu H, Hao Y, Wu G (2024) Removal of inflammatory factors and prognosis of patients with septic shock complicated with acute kidney injury by hemodiafiltration combined with HA330-II hemoperfusion. Ther Apher Dial 28:460\u2013466. https:\/\/doi.org\/10.1111\/1744-9987.14108","journal-title":"Ther Apher Dial"},{"key":"6882_CR41","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1744-9987.2012.01083.x","volume":"17","author":"Z Huang","year":"2013","unstructured":"Huang Z, Wang SR, Yang ZL, Liu JY (2013) Effect on extrapulmonary sepsis-induced acute lung injury by hemoperfusion with neutral microporous resin column. Ther Apher Dial 17:454\u2013461. https:\/\/doi.org\/10.1111\/j.1744-9987.2012.01083.x","journal-title":"Ther Apher Dial"},{"key":"6882_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.672260","volume":"9","author":"V Sazonov","year":"2021","unstructured":"Sazonov V, Abylkassov R, Tobylbayeva Z, Saparov A, Mironova O, Poddighe D (2021) Case series: efficacy and safety of hemoadsorption with HA-330 adsorber in septic pediatric patients with cancer. Front Pediatr 9:672260. https:\/\/doi.org\/10.3389\/fped.2021.672260","journal-title":"Front Pediatr"},{"key":"6882_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000535575","volume":"14","author":"C Pace Napoleone","year":"2024","unstructured":"Pace Napoleone C, Aidala E, Cascarano MT, Deorsola L, Iannandrea S, Longobardo A, Bonaveglio E, Zanin M, Peruzzi L (2024) Hemoadsorption contribution in failing fontan pediatric heart transplantation. Cardiorenal Med 14:67\u201373. https:\/\/doi.org\/10.1159\/000535575","journal-title":"Cardiorenal Med"},{"key":"6882_CR44","doi-asserted-by":"crossref","unstructured":"Gao Q, Xin XW, Zhao C, Wang YJ, Wang W, Yin Y ... Jin YP (2022) Efficacy of HA330-II column hemoadsorption in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis combined with liver failure: a case report. World J Hematol\u00a09:6\u201312","DOI":"10.5315\/wjh.v9.i1.6"},{"key":"6882_CR45","doi-asserted-by":"publisher","unstructured":"Wu C, Peng W, Cheng D, Gu H, Liu F, Peng S, Fu L (2023) Efficacy and economic evaluation of nonbiological artificial liver therapy in acute-on-chronic hepatitis B liver failure. J Clin Transl Hepatol 11:433\u2013440. https:\/\/doi.org\/10.14218\/JCTH.2022.00106","DOI":"10.14218\/JCTH.2022.00106"},{"key":"6882_CR46","doi-asserted-by":"publisher","first-page":"300060520932053","DOI":"10.1177\/0300060520932053","volume":"48","author":"X Guo","year":"2020","unstructured":"Guo X, Wu F, Guo W, Zhang J, Yang Y, Lu Y, Yin C, Fan H, Xu J, Liao M (2020) Comparison of plasma exchange, double plasma molecular adsorption system, and their combination in treating acute-on-chronic liver failure. J Int Med Res 48:300060520932053. https:\/\/doi.org\/10.1177\/0300060520932053","journal-title":"J Int Med Res"},{"key":"6882_CR47","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2147\/TCRM.S485620","volume":"20","author":"Y Xiang","year":"2024","unstructured":"Xiang Y, Li R, Cai J, Jiang Q (2024) Three artificial liver models of treatment of acute-on-chronic liver failure. Ther Clin Risk Manag 20:731\u2013740. https:\/\/doi.org\/10.2147\/TCRM.S485620","journal-title":"Ther Clin Risk Manag"},{"key":"6882_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28650","volume":"95","author":"W Xu","year":"2023","unstructured":"Xu W, Zhu S, Yang L, Li Z, Wu L, Zhang Y, Chen J, Deng Z, Luo Q, Peng L (2023) Safety and efficacy of double plasma molecular adsorption system with sequential low-volume plasma exchange in intermediate-stage hepatitis B virus-related acute-on-chronic liver failure. J Med Virol 95:e28650. https:\/\/doi.org\/10.1002\/jmv.28650","journal-title":"J Med Virol"},{"key":"6882_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/jca.22140","volume":"39","author":"L Zhang","year":"2024","unstructured":"Zhang L, Ma Y, Wang X, Ma LN, Ma W, Ding XC (2024) Comparative efficacy of double plasma molecular adsorption system combined with plasma exchange versus plasma exchange in treating acute-on-chronic liver failure due to hepatitis B: A meta-analysis. J Clin Apher 39:e22140. https:\/\/doi.org\/10.1002\/jca.22140","journal-title":"J Clin Apher"},{"key":"6882_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2020.100290","volume":"23","author":"CF Yang","year":"2021","unstructured":"Yang CF, Zhang Z, Zhang XY, Li YM (2021) Artificial liver support system in pediatric acute liver failure due to mushroom poisoning: Case series. Ann Hepatol 23:100290. https:\/\/doi.org\/10.1016\/j.aohep.2020.100290","journal-title":"Ann Hepatol"},{"key":"6882_CR51","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1097\/MPG.0000000000003759","volume":"76","author":"Q Gao","year":"2023","unstructured":"Gao Q, Chen J, Zhao C, Li J, Song A, Zhang Z, Lin X, Dong S, Xin M, Hou J, Han M, Li X, Yang X, Jin Y, Zhang Y (2023) Combination of plasma exchange and adsorption versus plasma exchange in pediatric acute liver failure: a multicenter cohort study. J Pediatr Gastroenterol Nutr 76:710\u2013715. https:\/\/doi.org\/10.1097\/MPG.0000000000003759","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6882_CR52","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000493909","volume":"47","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Li L, Zhang X, Xu W, Guo Q, Zhou J (2019) Plasmapheresis combined with continuous plasma filtration adsorption rescues severe acute liver failure in Wilson\u2019s disease before liver transplantation. Blood Purif 47:120\u2013125. https:\/\/doi.org\/10.1159\/000493909","journal-title":"Blood Purif"},{"key":"6882_CR53","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1001\/jama.2009.856","volume":"301","author":"DN Cruz","year":"2009","unstructured":"Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C (2009) Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 301:2445\u20132452. https:\/\/doi.org\/10.1001\/jama.2009.856","journal-title":"JAMA"},{"key":"6882_CR54","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","volume":"41","author":"Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, Pottecher J, Joannes-Boyau O, Martin-Lefevre L, Jabaudon M, Mimoz O, Coudroy R, Ferrandi\u00e8re M, Kipnis E, Vela C, Chevallier S, Mallat J, Robert R, ABDOMIX Group","year":"2015","unstructured":"Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, Pottecher J, Joannes-Boyau O, Martin-Lefevre L, Jabaudon M, Mimoz O, Coudroy R, Ferrandi\u00e8re M, Kipnis E, Vela C, Chevallier S, Mallat J, Robert R, ABDOMIX Group (2015) Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med 41:975\u2013984. https:\/\/doi.org\/10.1007\/s00134-015-3751-z","journal-title":"Intensive Care Med"},{"key":"6882_CR55","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2018.14618","volume":"320","author":"RP Dellinger","year":"2018","unstructured":"Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, Palevsky PM, Weisberg LS, Schorr CA, Trzeciak S, Walker PM; EUPHRATES Trial Investigators (2018) Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. JAMA 320:1455\u20131463. https:\/\/doi.org\/10.1001\/jama.2018.14618","journal-title":"JAMA"},{"key":"6882_CR56","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/ped.13348","volume":"59","author":"N Nishizaki","year":"2017","unstructured":"Nishizaki N, Hirano D, Miyasho T, Obinata K, Shoji H, Shimizu T (2017) Evaluation of urinary IL-6 in neonates with septic shock treated with polymyxin B-immobilized fiber column. Pediatr Int 59:1032\u20131033. https:\/\/doi.org\/10.1111\/ped.13348","journal-title":"Pediatr Int"},{"key":"6882_CR57","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1111\/ped.12029","volume":"55","author":"E Hirakawa","year":"2013","unstructured":"Hirakawa E, Ibara S, Tokuhisa T, Hiwatashi S, Hayashida Y, Maede Y, Matsui T, Nakazawa Y, Inoue T, Kodaira Y (2013) Septic neonate rescued by polymyxin B hemoperfusion. Pediatr Int 55:e70\u2013e72. https:\/\/doi.org\/10.1111\/ped.12029","journal-title":"Pediatr Int"},{"key":"6882_CR58","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/SHK.0000000000001016","volume":"49","author":"M Yaroustovsky","year":"2018","unstructured":"Yaroustovsky M, Abramyan M, Komardina E, Nazarova H, Popov D, Plyushch M, Soldatkina A, Rogalskaya E (2018) Selective LPS adsorption using polymyxin B-immobilized fiber cartridges in sepsis patients following cardiac surgery. Shock 49:658\u2013666. https:\/\/doi.org\/10.1097\/SHK.0000000000001016","journal-title":"Shock"},{"key":"6882_CR59","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1097\/PCC.0000000000002969","volume":"23","author":"P Saetang","year":"2022","unstructured":"Saetang P, Samransamruajkit R, Singjam K, Deekajorndech T (2022) Polymyxin B hemoperfusion in pediatric septic shock: single-center observational case series. Pediatr Crit Care Med 23:e386\u2013e391. https:\/\/doi.org\/10.1097\/PCC.0000000000002969","journal-title":"Pediatr Crit Care Med"},{"key":"6882_CR60","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/ped.12825","volume":"58","author":"N Nishizaki","year":"2016","unstructured":"Nishizaki N, Nakagawa M, Hara S, Oda H, Kantake M, Obinata K, Uehara Y, Hiramatsu K, Shimizu T (2016) Effect of PMX-DHP for sepsis due to ESBL-producing E. coli in an extremely low-birthweight infant. Pediatr Int 58:411\u2013414. https:\/\/doi.org\/10.1111\/ped.12825","journal-title":"Pediatr Int"},{"key":"6882_CR61","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000510126","volume":"50","author":"M Yaroustovsky","year":"2021","unstructured":"Yaroustovsky M, Abramyan M, Rogalskaya E, Komardina E (2021) Selective polymyxin hemoperfusion in complex therapy of sepsis in children after cardiac surgery. Blood Purif 50:222\u2013229. https:\/\/doi.org\/10.1159\/000510126","journal-title":"Blood Purif"},{"key":"6882_CR62","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/PCC.0000000000002132","volume":"21","author":"N Nishizaki","year":"2020","unstructured":"Nishizaki N, Hara T, Obinata K, Nakagawa M, Shimizu T (2020) Clinical effects and outcomes after polymyxin B-immobilized fiber column direct hemoperfusion treatment for septic shock in preterm neonates. Pediatr Crit Care Med 21:156\u2013163. https:\/\/doi.org\/10.1097\/PCC.0000000000002132","journal-title":"Pediatr Crit Care Med"},{"key":"6882_CR63","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1159\/000531356","volume":"52","author":"V Premuzic","year":"2023","unstructured":"Premuzic V, Situm I, Lovric D, Erceg A, Karmelic D, Mogus M, Jurjevic M, Nedeljkovic V, Mazar M, Mihaljevic S, Villa G, Ronco C (2023) Sequential extracorporeal blood purification is associated with prolonged survival among ICU patients with COVID-19 and confirmed bacterial superinfection. Blood Purif 52:642\u2013651. https:\/\/doi.org\/10.1159\/000531356","journal-title":"Blood Purif"},{"key":"6882_CR64","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/ndt\/gfab347","volume":"37","author":"JJ Schmidt","year":"2022","unstructured":"Schmidt JJ, Borchina DN, Van\u2019t Klooster M, Bulhan-Soki K, Okioma R, Herbst L, Rodr\u00edguez DS, Premu\u017ei\u0107 V, B\u00fcttner S, Bader B, Serednicki W, Zasada E, Schmitz M, Quabach RA, Hrincheva M, F\u00fchner T, Kielstein JT (2022) Interim analysis of the COSA (COVID-19 patients treated with the Seraph\u00ae 100 Microbind\u00ae Affinity filter) registry. Nephrol Dial Transplant 37:673\u2013680. https:\/\/doi.org\/10.1093\/ndt\/gfab347","journal-title":"Nephrol Dial Transplant"},{"key":"6882_CR65","doi-asserted-by":"publisher","unstructured":"Chitty SA, Mobbs S, Rifkin BS, Stogner SW, Lewis MS, Betancourt J, DellaVolpe J, Abouzahr F, Wilhelm AM, Szerlip HM, Parikh A, Gaeta RM, Rivera I, Park C, Levi B, Anesi GL, Alcover KC, Arnold TB, Howard JT, Sharma K \u2026 Chung KK (2022) A multicenter evaluation of the Seraph 100 microbind affinity blood filter for the treatment of severe COVID-19. Crit Care Explor 4:e0662. https:\/\/doi.org\/10.1097\/CCE.0000000000000662","DOI":"10.1097\/CCE.0000000000000662"},{"key":"6882_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000527290","volume":"13","author":"KA Merrill","year":"2023","unstructured":"Merrill KA, Krallman KA, Loeb D, Standage SW, Mattoon D, Shan D, Goldstein SL, Schuh MP (2023) First-time use of the Seraph\u00ae 100 Microbind\u00aeAffinity blood filter in an adolescent patient with severe COVID-19 disease: a case report. Case Rep Nephrol Dial 13:1\u20136. https:\/\/doi.org\/10.1159\/000527290","journal-title":"Case Rep Nephrol Dial"},{"key":"6882_CR67","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00467-023-06097-4","volume":"39","author":"DS Li","year":"2024","unstructured":"Li DS, Burke TM, Smith JM, Reed RC, Okamura DM, Menon S (2024) Use of the Seraph\u00ae 100 Microbind\u00ae Affinity Blood Filter in an adolescent patient with disseminated adenoviral disease. Pediatr Nephrol 39:331\u2013335. https:\/\/doi.org\/10.1007\/s00467-023-06097-4","journal-title":"Pediatr Nephrol"},{"key":"6882_CR68","doi-asserted-by":"publisher","DOI":"10.1111\/petr.70055","volume":"29","author":"M Harris","year":"2025","unstructured":"Harris M, Keswani M, Mottes T, Heald-Sargent T, Verghese PS (2025) Seraph 100 microbind affinity blood filter for persistent pediatric BK virus nephropathy. Pediatr Transplant 29:e70055. https:\/\/doi.org\/10.1111\/petr.70055","journal-title":"Pediatr Transplant"},{"key":"6882_CR69","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/03913988221107947","volume":"45","author":"J Feng","year":"2022","unstructured":"Feng J, Zhang S, Ai T, Wang L, Gao Y, Li W, Zhu M (2022) Effect of CRRT with oXiris filter on hemodynamic instability in surgical septic shock with AKI: a pilot randomized controlled trial. Int J Artif Organs 45:801\u2013808. https:\/\/doi.org\/10.1177\/03913988221107947","journal-title":"Int J Artif Organs"},{"key":"6882_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220444","volume":"14","author":"ME Broman","year":"2019","unstructured":"Broman ME, Hansson F, Vincent JL, Bodelsson M (2019) Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: a randomized crossover double-blind study. PLoS One 14:e0220444. https:\/\/doi.org\/10.1371\/journal.pone.0220444","journal-title":"PLoS ONE"},{"key":"6882_CR71","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13054-023-04555-x","volume":"27","author":"G Wang","year":"2023","unstructured":"Wang G, He Y, Guo Q, Zhao Y, He J, Chen Y, Chen W, Zhou Y, Peng Z, Deng K, Guan J, Xie W, Chang P, Liu Z (2023) Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: a systematic review and meta-analysis. Crit Care 27:275. https:\/\/doi.org\/10.1186\/s13054-023-04555-x","journal-title":"Crit Care"},{"key":"6882_CR72","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.2169\/internalmedicine.2708-23","volume":"63","author":"K Kinjoh","year":"2024","unstructured":"Kinjoh K, Nagamura R, Sakuda Y (2024) A retrospective study on the start and end of continuous hemodialysis using a polymethylmethacrylate hemofilter for severe acute pancreatitis. Intern Med 63:2241\u20132249. https:\/\/doi.org\/10.2169\/internalmedicine.2708-23","journal-title":"Intern Med"},{"key":"6882_CR73","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2119\/2007-00108.Nakada","volume":"14","author":"TA Nakada","year":"2008","unstructured":"Nakada TA, Oda S, Matsuda K, Sadahiro T, Nakamura M, Abe R, Hirasawa H (2008) Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock. Mol Med 14:257\u2013263. https:\/\/doi.org\/10.2119\/2007-00108.Nakada","journal-title":"Mol Med"},{"key":"6882_CR74","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s10047-018-1025-6","volume":"21","author":"H Mukaida","year":"2018","unstructured":"Mukaida H, Matsushita S, Inotani T, Nakamura A, Amano A (2018) Continuous renal replacement therapy with a polymethyl methacrylate membrane hemofilter suppresses inflammation in patients after open-heart surgery with cardiopulmonary bypass. J Artif Organs 21:188\u2013195. https:\/\/doi.org\/10.1007\/s10047-018-1025-6","journal-title":"J Artif Organs"},{"key":"6882_CR75","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.transci.2008.11.001","volume":"40","author":"Y Tateishi","year":"2009","unstructured":"Tateishi Y, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Abe R, Hirasawa H (2009) Continuous hemodiafiltration in the treatment of reactive hemophagocytic syndrome refractory to medical therapy. Transfus Apher Sci 40:33\u201340. https:\/\/doi.org\/10.1016\/j.transci.2008.11.001","journal-title":"Transfus Apher Sci"},{"key":"6882_CR76","doi-asserted-by":"publisher","first-page":"352","DOI":"10.5761\/atcs.oa.10.01584","volume":"17","author":"T Miyamoto","year":"2011","unstructured":"Miyamoto T, Yoshimoto A, Tatsu K, Ikeda K, Ishii Y, Kobayashi T (2011) Zero mortality of continuous veno-venous hemodiafiltration with PMMA hemofilter after pediatric cardiac surgery. Ann Thorac Cardiovasc Surg 17:352\u2013355. https:\/\/doi.org\/10.5761\/atcs.oa.10.01584","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"6882_CR77","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3390\/antibiotics12091395","volume":"12","author":"G Bottari","year":"2023","unstructured":"Bottari G, Goffredo BM, Marano M, Maccarrone C, Simeoli R, Bianco G, Vallesi L, Beetham JCC, Mazzeo AT, Cappoli A, Cairoli S, Labbadia R, Cecchetti C, Bernaschi P, Corsetti T, Morabito S, Taccone FS, Guzzo I (2023) Impact of continuous kidney replacement therapy and hemoadsorption with CytoSorb on antimicrobial drug removal in critically ill children with septic shock: a single-center prospective study on a pediatric cohort. Antibiotics 12:1395. https:\/\/doi.org\/10.3390\/antibiotics12091395","journal-title":"Antibiotics"},{"key":"6882_CR78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40635-025-00716-0","volume":"13","author":"G Asgarpur","year":"2025","unstructured":"Asgarpur G, Weber F, Kiessling P, Akbari N, Stroben F, Kleikamp B, Kloft C, Treskatsch S, Angermair S (2025) Impact of hemoadsorption with CytoSorb\u00ae on meropenem and piperacillin exposure in critically ill patients in a post-CKRT setup: a single-center retrospective data analysis. Intensive Care Med Exp 13:7. https:\/\/doi.org\/10.1186\/s40635-025-00716-0","journal-title":"Intensive Care Medicine Exp"},{"key":"6882_CR79","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000542332","volume":"54","author":"T Furukawa","year":"2025","unstructured":"Furukawa T, Lankadeva Y, Baldwin I, Ow PCC, Hood S, Schneider A, Decosterd LA, May CN, Bellomo R (2025) Removal of meropenem and piperacillin during experimental hemoadsorption with the HA380 cartridge. Blood Purif 54:102\u2013110. https:\/\/doi.org\/10.1159\/000542332","journal-title":"Blood Purif"},{"key":"6882_CR80","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jiac.2020.04.001","volume":"26","author":"K Oda","year":"2020","unstructured":"Oda K, Jono H, Sagishima K, Saito H (2020) Augmented teicoplanin clearance through probable adsorption onto a polymethyl methacrylate (PMMA) hemofilter during continuous venovenous hemodiafiltration. J Infect Chemother 26:992\u2013994. https:\/\/doi.org\/10.1016\/j.jiac.2020.04.001","journal-title":"J Infect Chemother"},{"key":"6882_CR81","doi-asserted-by":"publisher","DOI":"10.1111\/aor.14980","author":"T Hiraiwa","year":"2025","unstructured":"Hiraiwa T, Kuriyama N, Moriyama K, Yamada S, Nakamura T, Nishida O (2025) In vitro evaluation of liposomal amphotericin B adsorption with different hemofilters for continuous hemofiltration. Artif Organs. https:\/\/doi.org\/10.1111\/aor.14980","journal-title":"Artif Organs"},{"key":"6882_CR82","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000504039","volume":"49","author":"T Hiraiwa","year":"2020","unstructured":"Hiraiwa T, Moriyama K, Matsumoto K, Shimomura Y, Kato Y, Yamashita C, Hara Y, Kawaji T, Kurimoto Y, Nakamura T, Kuriyama N, Shibata J, Komura H, Morita K, Nishida O (2020) In vitro evaluation of linezolid and doripenem clearance with different hemofilters. Blood Purif 49:295\u2013301. https:\/\/doi.org\/10.1159\/000504039","journal-title":"Blood Purif"},{"key":"6882_CR83","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.colsurfb.2011.09.046","volume":"90","author":"K Shimokawa","year":"2012","unstructured":"Shimokawa K, Takakuwa R, Taya K, Wada Y, Yamazaki N, Murata M, Hirata K, Masuno T, Yokota H, Ishii F (2012) Adsorption of various antimicrobial agents to endotoxin removal polymyxin-B immobilized fiber (Toraymyxin\u00ae). Colloids Surf B Biointerfaces 90:58\u201361. https:\/\/doi.org\/10.1016\/j.colsurfb.2011.09.046","journal-title":"Colloids Surf B Biointerfaces"},{"key":"6882_CR84","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.colsurfb.2012.06.032","volume":"101","author":"K Shimokawa","year":"2013","unstructured":"Shimokawa K, Takakuwa R, Wada Y, Yamazaki N, Ishii F (2013) Adsorption of various antimicrobial agents to endotoxin removal polymyxin-B immobilized fiber (Toraymyxin\u00ae). Part 2: Adsorption of two drugs to Toraymyxin PMX-20R cartridges. Colloids Surf B Biointerfaces 101:350\u2013352. https:\/\/doi.org\/10.1016\/j.colsurfb.2012.06.032","journal-title":"Colloids Surf B Biointerfaces"},{"key":"6882_CR85","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/MAT.0000000000001513","volume":"67","author":"TC Lewis","year":"2021","unstructured":"Lewis TC, Merchan C, Toy B, Goldenberg RM, Geraci TC, Chang SH, Galloway AC, Smith DE 3rd, Moazami N (2021) Impact of cytosorb hemoadsorption on sedation requirements in patients with severe COVID-19 on venovenous extracorporeal membrane oxygenation. ASAIO J 67:856\u2013861. https:\/\/doi.org\/10.1097\/MAT.0000000000001513","journal-title":"ASAIO J"},{"key":"6882_CR86","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000542009","volume":"54","author":"CI Brozat","year":"2025","unstructured":"Brozat CI, Zoller M, Frank S, Bruegel M, Gr\u00e4fe C, Rebholz D, Paal M, Graf H, Liebchen U, Scharf C (2025) Albumin and platelet loss during the application of CytoSorb\u00ae in critically ill patients: a post hoc analysis of the Cyto-SOLVE trial. Blood Purif 54:93\u2013101. https:\/\/doi.org\/10.1159\/000542009","journal-title":"Blood Purif"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06882-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06882-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06882-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:02:04Z","timestamp":1769608924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06882-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["6882"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06882-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}